Sorenson, Corinna (2009) The role of HTA in coverage and pricing decisions: a cross-country comparison. Euro Observer, 11 (1). pp. 1-4. ISSN 1020-7481
Full text not available from this repository.Abstract
Since the late 1970s, many European countries have established health technology assessment (HTA) systems to inform coverage and pricing decisions. These countries use HTA to systematically determine the relative ‘value for money’ provided by new technologies and to give providers and patients information to make treatment choices. This, in turn, serves to encourage the efficient and effective use of health technologies and to support innovation by identifying and rewarding high-value products. This overview article explores the use of HTA in coverage and pricing decisions, with a focus on pharmaceuticals, in six European countries with established HTA systems – Denmark, England, France, Germany, the Netherlands and Sweden.
| Item Type: | Article |
|---|---|
| Official URL: | http://www.euro.who.int/en/who-we-are/partners/obs... |
| Additional Information: | © 2009 European Observatory on Health Systems and Policies |
| Divisions: | LSE Health |
| Subjects: | T Technology > T Technology (General) R Medicine > RA Public aspects of medicine |
| Date Deposited: | 03 Dec 2009 13:40 |
| Last Modified: | 11 Dec 2024 23:30 |
| URI: | http://eprints.lse.ac.uk/id/eprint/26129 |
Actions (login required)
 |
View Item |
